Atıf Formatları
Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

C. Aypak Et Al. , "Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures," Rambam Maimonides Medical Journal , vol.13, no.3, 2022

Aypak, C. Et Al. 2022. Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures. Rambam Maimonides Medical Journal , vol.13, no.3 .

Aypak, C., Bircan, M. A., & Özdemir, A., (2022). Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures. Rambam Maimonides Medical Journal , vol.13, no.3.

Aypak, Cenk, Mustafa A. Bircan, And Ayşe Özdemir. "Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures," Rambam Maimonides Medical Journal , vol.13, no.3, 2022

Aypak, Cenk Et Al. "Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures." Rambam Maimonides Medical Journal , vol.13, no.3, 2022

Aypak, C. Bircan, M. A. And Özdemir, A. (2022) . "Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures." Rambam Maimonides Medical Journal , vol.13, no.3.

@article{article, author={Cenk Aypak Et Al. }, title={Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures}, journal={Rambam Maimonides Medical Journal}, year=2022}